Tag: ANA

Jun 03, 2026

• ANA
• antinuclear-antibody
• dengue
• autoimmunity
• molecular-mimicry
• bystander-activation
• epitope-spreading
• post-dengue
• IIF
• HEp-2
• LIA
• prevalence
• healthy-population
• acute-phase
• IIFA
• FcγRIIa
• NS1
• MAS
• HLH
• macrophage-activation
• NS1-IgG-kinetics
• primary-infection
• PAIgG
• PAIgM
• ANA-negative
• polyreactive-IgM
• nuclear-antigen-consumption
• thrombocytopenia-bifurcation
• immune-complex
• anti-prM
• vaccine-design
• P311-330
• PDI
• epitope-mapping
• FcγRIIa-paradox
• anti-EC-isotype-shift
• dengue-mimickers
• false-positive-serology
• SLE-dengue-differential
• literature-review
• synthesis

Jun 03, 2026

• ANA
• antinuclear-antibody
• autoimmunity
• IIF
• HEp-2
• prevalence
• SLE
• healthy-population
• viral-infection
• acute-dengue
• LIA
• India
• polyreactive-antibodies
• post-dengue
• 6-month-follow-up
• fatigue
• PIF
• evidence-gap

Jun 03, 2026

• autoimmunity
• immune-complex
• ANA
• CRP
• cytokines
• molecular-mimicry
• NS1
• post-dengue
• infection-triggered-autoimmunity
• thrombocytopenia
• endothelial-cells
• ADEM
• encephalomyelitis
• epidemiology
• MCTD
• myositis
• LIA
• India
• sex-bias
• host-factors
• adrenocortical-insufficiency
• TLR
• Taiwan
• NHIRD
• MAS
• macrophage-activation-syndrome
• HLH
• Paraguay
• SLE
• lupus-nephritis
• ANA-negative
• PAIgG
• secondary-infection
• Philippines
• polyreactive-antibodies
• 6-month-follow-up
• PDI
• HSP60
• P311-330
• Vietnam
• infants
• primary-infection
• thrombomodulin
• anti-platelet
• anti-endothelial
• infection-order

May 25, 2026

• methodology
• critique
• ANA
• IIFA
• case-control
• matching
• study-design
• autoimmunity
• abstract-review

Apr 19, 2026

• ANA
• antinuclear-antibody
• dengue
• autoimmunity
• molecular-mimicry
• bystander-activation
• epitope-spreading
• post-dengue
• IIF
• HEp-2
• LIA
• prevalence
• healthy-population
• acute-phase
• IIFA
• FcγRIIa
• NS1
• MAS
• HLH
• macrophage-activation
• NS1-IgG-kinetics
• primary-infection
• PAIgG
• PAIgM
• ANA-negative
• Talib2013
• literature-review
• autoantigen-microarray
• nuclear-antigen-consumption
• thrombocytopenia-bifurcation
• immune-complex

Apr 19, 2026

• autoimmunity
• molecular-mimicry
• bystander-activation
• epitope-spreading
• viral-infection
• ANA
• autoantibodies
• post-infectious
• NS1
• dengue-specific
• ADEM
• epidemiology
• polyreactive-antibodies
• 6-month-follow-up
• primary-infection
• infants
• anti-platelet
• anti-endothelial
• Vietnam

Apr 18, 2026

• India
• Kolkata
• Manipal
• Karnataka
• Gwalior
• Madhya-Pradesh
• Lucknow
• Uttar-Pradesh
• New-Delhi
• dengue-epidemiology
• endemic
• Southeast-Asia
• Indian-subcontinent
• ANA
• pathogenesis-review
• seroconversion
• 1996-epidemic

Apr 18, 2026

• IIF
• indirect-immunofluorescence
• ANA
• HEp-2
• autoantibody-testing
• diagnostic-method
• dengue
• acute-infection
• post-dengue
• 6-month-follow-up
• India

Apr 18, 2026

• autoantibodies
• ANA
• anti-smooth-muscle
• acute-viral-hepatitis
• infection-triggered-autoimmunity
• transient-autoimmunity
• indirect-immunofluorescence
• Brazil
• comparator-baseline

Apr 18, 2026

• autoimmunity
• ANA
• cryoglobulinemia
• DHF
• case-report
• Brazil
• DENV-3
• complement
• DIC
• serositis
• LE-cells
• mitotic-spindle
• secondary-infection
• cryoglobulins
• thrombocytopenia
• IgM-IgG-serology

Apr 17, 2026

• ANA
• antinuclear-antibody
• dengue
• seroconversion
• IgG
• IIFA
• HEp-2
• India
• Madhya-Pradesh
• post-dengue
• autoimmunity
• prospective

Apr 17, 2026

• autoimmunity
• SLE
• lupus-nephritis
• case-report
• India
• Mumbai
• DENV-1
• primary-infection
• ANA
• anti-dsDNA
• anti-cardiolipin
• glomerulonephritis
• immune-complex
• dengue-trigger

Apr 17, 2026

• autoimmunity
• SLE
• systemic-lupus-erythematosus
• ANA
• anti-dsDNA
• antinucleosome
• dengue
• pediatric
• case-series
• molecular-mimicry
• NS1
• FcR
• immune-complex
• Mexico
• thrombocytopenia
• severe-dengue
• lupus-nephritis
• hypocomplementemia

Apr 13, 2026

• gap-analysis
• wiki-state
• research-priorities
• ANA
• autoimmunity
• NS1
• molecular-mimicry
• FcγRIIa
• diagnostics
• geography
• post-dengue

Apr 12, 2026

• reading-plan
• ANA
• autoimmunity
• dengue
• study-order

Apr 12, 2026

• gap-analysis
• wiki-state
• research-priorities
• post-dengue
• NS1
• molecular-mimicry
• FcγRIIa
• ANA
• diagnostics

Apr 12, 2026

• LIA
• line-immunoassay
• ANA
• autoantibody
• ENA
• confirmatory-test
• specificity
• dengue
• DFS70

Apr 12, 2026

• SLE
• classification-criteria
• EULAR
• ACR
• ANA
• entry-criterion
• HEp-2
• lupus
• validation

Apr 12, 2026

• ANA
• autoantibodies
• viral-infection
• bacterial-infection
• parasitic-infection
• ELISA
• acute-infection
• healthy-controls

Apr 12, 2026

• ANA
• IIFA
• LIA
• autoimmunity
• MCTD
• myositis
• India
• Kolkata
• acute-dengue
• HEp-2
• line-immunoassay
• cross-sectional

Apr 12, 2026

• ANA
• antinuclear-antibody
• NHANES
• prevalence
• temporal-trend
• United-States
• IIF
• HEp-2
• adolescents

Apr 12, 2026

• ANA
• antinuclear-antibody
• China
• prevalence
• healthy-population
• IIF
• HEp-2
• AMA-M2
• anti-SSA
• primary-biliary-cholangitis

Apr 12, 2026

• ANA
• antinuclear-antibody
• NHANES
• prevalence
• United-States
• sociodemographic
• immunofluorescence
• HEp-2

Apr 12, 2026

• ANA
• antinuclear-antibody
• healthy-population
• normal-range
• IIF
• HEp-2
• multicenter
• rheumatology